Oncology Imaging

A new imaging collaboration between researchers at the Walter and Eliza Hall Institute’s Center for Dynamic Imaging in Australia has revealed cancer cell findings that may help predict how cells respond to chemotherapy and our overall understanding of the disease, according to a release from the Institute.

"Several studies have shown that the size of different organs is an important factor in cancer development. For example, women with larger breasts have a greater risk of breast cancer. We wanted to check if this was also the case for brain tumors," said lead author of a new study, Even Hovig Fyllingen, in a prepared statement.

Stereotactic body radiation therapy (SBRT) is both safe and effective for men with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Stereotactic radiation therapy is a safe and effective treatment for cancer patients with only one kidney, according to research presented at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Contrary to recent data suggesting African-Americans face a higher mortality risk from prostate cancer than Caucasian men, a new study presented at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting suggests African-American men may have higher cure rates when treated with radiation therapy than Caucasian men.

Researchers have found diffusion-weighted magnetic resonance imaging (DWI) or gadolinium-enhanced T1-weighted volumetric interpolated breath-hold examination (VIBE) sequences are the most efficient MRI sequences for prostate cancer diagnosis, according to new research published online on Oct. 17 in the American Journal of Roentgenology.

A $1.6 million, four-year grant from the National Cancer Institute of the National Institutes of Health (NIH) was awarded to a researcher from Tulane University in Louisiana to develop a prostate cancer scanner that can check whether all traces of cancer have been removed after surgery, according to The Associated Press.

Results of a new randomized, phase II clinical trial have demonstrated an aggressive form of precision radiation therapy can increase the lifespan of oligometastatic cancer patients and doubles how long they can live without cancer, according to the American Society for Radiation Oncology (ASTRO).

A multi-year, Swedish study found three-dimensional (3D) mammography detected over 30 percent more cancers compared to traditional mammography, according to a new 15,000-woman study published in The Lancet Oncology.

Using microscopic imaging, researchers from the University of Calgary in Alberta, Canada have shown how the kidneys negatively respond to contrast dyes used during various medical tests and procedures, according to a university press release published Oct. 15.

More frequent surveillance imaging does not improve overall survival or post-recurrence survival for patients with non-small cell lung cancer (NSCLC), according to research published in the October issue of Annals of Surgery.

Prominent medical societies have issued new clinical guidelines, Thursday, Oct. 11, recommending physicians use external beam radiation therapy (EBRT) to treat men with early-stage prostate cancer.